- Home
- MKTX vs CAI Comparison
MKTX vs CAI Comparison
Compare MKTX & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKTX | CAI |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.0B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | MKTX | CAI |
|---|---|---|
| Price | $183.05 | $18.50 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $204.44 | $33.67 |
| AVG Volume (30 Days) | 498.4K | ★ 2.0M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.64 | N/A |
| Revenue | ★ $397,471,000.00 | N/A |
| Revenue This Year | $10.06 | $24.26 |
| Revenue Next Year | $7.20 | $22.60 |
| P/E Ratio | $27.95 | ★ N/A |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $156.17 | $17.15 |
| 52 Week High | $232.84 | $42.50 |
Technical Indicators
Market Signals| Indicator | MKTX | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 53.20 | 36.87 |
| Support Level | $183.00 | $17.15 |
| Resistance Level | $183.23 | $21.47 |
| Average True Range (ATR) | 4.53 | 1.27 |
| MACD | -0.27 | 0.13 |
| Stochastic Oscillator | 37.26 | 31.13 |
Price Performance
Historical ComparisonAbout MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
About CAI Caris Life Sciences Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.